Background Invasive differentiated thyroid cancer (DTC) is relatively frequent, yet there is a
paucity of specific guidelines devoted to its management. The Endocrine Committee of the …

Abstract This American Head and Neck Society (AHNS) consensus statement focuses on
the detection and management of recurrent thyroid cancer. This document describes the …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Context: Thyroid cancer is among the 10 most common malignancies in populations in the
Asia Pacific region, where access to various relevant health care resources varies widely …

Background: Invasive disease is a poor prognostic factor for patients with differentiated
thyroid cancer (DTC). Uncontrolled central neck disease is a common cause of distressing …

Thyroid cancer is the most common of the endocrine malignancies and it represents< 1% of
all human tumors. The annual incidence of thyroid cancer varies considerably by …

Spectrum of Behavior.-The clinical behavior of well-differentiated-papillary and follicular-
thyroid carcinoma has become increasingly clearer in recent years. Almost all physicians …

Importance Over time, the American Thyroid Association (ATA) guidelines have increasingly
promoted more limited treatments for well-differentiated thyroid cancers. Objective To …

Background: The American Thyroid Association (ATA) management guidelines for patients
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …

Thyroid cancer is the most common endocrine malignancy, although representing fewer
than 1% of all human tumors. Differentiated thyroid carcinoma (DTC) includes the papillary …